X2S.F Sinopharm Group Co. Ltd

Healthcare Health Care Providers & Services Frankfurt Exchange
4.52 EUR
Close of Nov 13, 2026
1.64 2.26
Market cap
EUR 6.06B
P/E
6.9x
P/B
0.52x
ROE
8.5%
Dividend yield
4.57%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is X2S.F undervalued?

Graham number
Price4.52
Graham value11.29
Discount60.0%

X2S.F trades 60.0% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sinopharm Group Co. Ltd fundamental analysis

No fundamental analysis for Sinopharm Group Co. Ltd yet.

Sinopharm Group Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sinopharm Group Co. Ltd

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. …

Full company profile